Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tetrahydrocannabinolic acid
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Inhalation, Oral, Sublingual, Buccal, Rectal, Topical, Transdermal, Intravenous, Intranasal, Ophthalmic
01
Overview
Tetrahydrocannabinolic acid (THCA) is a non-psychoactive cannabinoid and the acidic precursor to tetrahydrocannabinol (THC), found abundantly in raw and live cannabis plants. It converts to THC through a process called decarboxylation, typically induced by heat. THCA is being investigated for potential therapeutic properties, including anti-inflammatory, neuroprotective, and antiemetic effects, without producing the intoxicating effects associated with THC.
02
Targets
Anandamide reuptake transporterCNR2 (Cannabinoid receptor type 2)TRPV2 (Transient receptor potential cation channel subfamily V member 2)TRPV3 (Transient receptor potential vanilloid subtype 3)TRPV1 (Transient receptor potential cation channel subfamily V member 1)TRPV4 (Transient receptor potential cation channel subfamily V member 4)NAAA (N-acylethanolamine-hydrolyzing acid amidase)DAGLA (Diacylglycerol lipase alpha)TRPA1 (Transient receptor potential cation channel subfamily A member 1)MGL (Methionine gamma-lyase)PGHS-1 (Prostaglandin G/H Synthase 1)FAAHPC-PLC (Phosphatidylcholine-specific phospholipase C)
Beyond the preview
Go deeper on tetrahydrocannabinolic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tetrahydrocannabinolic acid.